- Home
- PRE vs TKNO Comparison
PRE vs TKNO Comparison
Compare PRE & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRE | TKNO |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 301.5M | 268.1M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PRE | TKNO |
|---|---|---|
| Price | $23.60 | $6.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $30.50 | N/A |
| AVG Volume (30 Days) | ★ 278.6K | 251.3K |
| Earning Date | 06-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $40,520,000.00 |
| Revenue This Year | $108.69 | $8.27 |
| Revenue Next Year | $58.68 | $13.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $9.29 | $1.91 |
| 52 Week High | $27.24 | $7.84 |
Technical Indicators
Market Signals| Indicator | PRE | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 54.71 | 50.70 |
| Support Level | $17.49 | $4.87 |
| Resistance Level | $27.24 | $7.66 |
| Average True Range (ATR) | 1.69 | 0.37 |
| MACD | -0.07 | -0.12 |
| Stochastic Oscillator | 63.62 | 12.90 |
Price Performance
Historical ComparisonAbout PRE Prenetics Global Limited
Prenetics Global Ltd is a consumer health and wellness company offering nutrition and longevity products through its flagship brand, IM8. It offers science-backed daily nutrition and longevity products distributed directly to consumers across multiple countries. The company's products are developed with scientific input and are subject to third-party quality certifications.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.